KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Invested Capital (2016 - 2026)

Edwards Lifesciences has reported Invested Capital over the past 17 years, most recently at $10.9 billion for Q4 2025.

  • For Q4 2025, Invested Capital rose 2.58% year-over-year to $10.9 billion; the TTM value through Dec 2025 reached $10.9 billion, up 2.58%, while the annual FY2025 figure was $10.9 billion, 2.58% up from the prior year.
  • Invested Capital for Q4 2025 was $10.9 billion at Edwards Lifesciences, up from $10.2 billion in the prior quarter.
  • Over five years, Invested Capital peaked at $10.9 billion in Q4 2025 and troughed at $4.7 billion in Q1 2021.
  • A 5-year average of $7.5 billion and a median of $6.6 billion in 2023 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: decreased 0.44% in 2022 and later soared 45.71% in 2024.
  • Year by year, Invested Capital stood at $6.4 billion in 2021, then fell by 0.44% to $6.4 billion in 2022, then increased by 14.27% to $7.3 billion in 2023, then skyrocketed by 45.71% to $10.7 billion in 2024, then rose by 2.58% to $10.9 billion in 2025.
  • Business Quant data shows Invested Capital for EW at $10.9 billion in Q4 2025, $10.2 billion in Q3 2025, and $10.6 billion in Q2 2025.